Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $CTSO vs $FEMY | Chartloom

Compare

$CTSO vs $FEMY

Cytosorbents Corp · Femasys Inc

CTSO

Cytosorbents Corp

FEMY

Femasys Inc

Compare $CTSO vs $FEMY

Comparing Cytosorbents Corp and Femasys Inc

CTSOCytosorbents Corp

FEMYFemasys Inc

CTSOCytosorbents Corp

Market cap

$217M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.02x

Rev growth (TTM)

8.6%

YTD performance

-73.6%

52W performance

-81.1%

FCF yield

-4.5%

FEMYFemasys Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.95x

Rev growth (TTM)

21.9%

YTD performance

-86.2%

52W performance

-85.6%

FCF yield

-342.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CTSO

FEMY

Detailed metrics comparison

CTSO

Cytosorbents Corp

FEMY

Femasys Inc

Market Cap

CTSO$217M

FEMY$5M

Enterprise Value

CTSO$230M

FEMY$7M

Price

CTSO$3.46

FEMY$1.76

P/E Ratio

CTSON/A

FEMYN/A

P/S Ratio

CTSO5.84x

FEMY2.31x

EV/Sales

CTSO6.19x

FEMY3.22x

EV/EBITDA

CTSO0.00x

FEMY0.00x

P/B Ratio

CTSO5.44x

FEMY4.16x

P/FCF Ratio

CTSON/A

FEMYN/A

EV/FCF

CTSO-23.75x

FEMY-0.41x

PEG Ratio

CTSON/A

FEMYN/A

Forward P/E (NTM)

CTSON/A

FEMYN/A

Forward P/S (NTM)

CTSO5.02x

FEMY0.95x

Revenue (TTM)

CTSO$37M

FEMY$2M

Revenue Growth (YoY)

CTSO8.6%

FEMY21.9%

Forward Rev Growth

CTSO13.6%

FEMY297.9%

Gross Margin (TTM)

CTSO71.6%

FEMY61.0%

Operating Margin (TTM)

CTSO0.0%

FEMY0.0%

EBITDA Margin (TTM)

CTSO-28.3%

FEMY-749.3%

Net Margin (TTM)

CTSO-48.9%

FEMY-511.8%

FCF Margin (TTM)

CTSO-26.0%

FEMY-791.0%

Net Income (TTM)

CTSO$-18M

FEMY$-12M

FCF (TTM)

CTSO$-10M

FEMY$-18M

EPS (TTM)

CTSO-$0.29

FEMY-$3.51

ROE (TTM)

CTSO-16513.0%

FEMY-21646.0%

ROA (TTM)

CTSO-4325.0%

FEMY-7154.0%

ROIC (TTM)

CTSO-5193.0%

FEMY-12206.0%

Cash

CTSO$4M

FEMY$1M

Debt

CTSO$17M

FEMY$4M

Net Cash/Debt

CTSO$-13M

FEMY$-2M

Current Ratio (TTM)

CTSO0.66x

FEMY2.14x

Quick Ratio (TTM)

CTSO0.47x

FEMY0.55x

Debt/Equity (TTM)

CTSO7.73x

FEMY0.87x

Debt/Assets (TTM)

CTSO0.0%

FEMY0.0%

Interest Coverage (TTM)

CTSON/A

FEMYN/A

Net Debt/EBITDA (TTM)

CTSO0.00x

FEMY0.00x

Beta

CTSO1.51

FEMY-2.33

52W Performance

CTSO-81.1%

FEMY-85.6%

YTD Performance

CTSO-73.6%

FEMY-86.2%

% from 52W High

CTSO-82.5%

FEMY-92.1%

% from 52W Low

CTSO1.1%

FEMY5.4%

Asset Turnover (TTM)

CTSO0.88x

FEMY0.14x

FCF Yield (TTM)

CTSO-4.5%

FEMY-342.2%

Earnings Yield (TTM)

CTSO-8.4%

FEMY-221.4%

Dividend Yield (TTM)

CTSON/A

FEMYN/A

Rule of 40

CTSO-17.4

FEMY-769.2

EV/GP/RG

CTSO0.53

FEMY0.04

Ticker research

View CTSO research View FEMY research

Metric	CTSO Cytosorbents Corp	FEMY Femasys Inc
Market & Valuation
Market Cap	$217M	$5M
Enterprise Value	$230M	$7M
Price	$3.46	$1.76
P/E Ratio	N/A	N/A
P/S Ratio	5.84x	2.31x
EV/Sales	6.19x	3.22x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.44x	4.16x
P/FCF Ratio	N/A	N/A
EV/FCF	-23.75x	-0.41x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.02x	0.95x
Revenue & Growth
Revenue (TTM)	$37M	$2M
Revenue Growth (YoY)	8.6%	21.9%
Forward Rev Growth	13.6%	297.9%
Profitability
Gross Margin (TTM)	71.6%	61.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-28.3%	-749.3%
Net Margin (TTM)	-48.9%	-511.8%
FCF Margin (TTM)	-26.0%	-791.0%
Net Income (TTM)	$-18M	$-12M
FCF (TTM)	$-10M	$-18M
EPS (TTM)	-$0.29	-$3.51
ROE (TTM)	-16513.0%	-21646.0%
ROA (TTM)	-4325.0%	-7154.0%
ROIC (TTM)	-5193.0%	-12206.0%
Financial Health
Cash	$4M	$1M
Debt	$17M	$4M
Net Cash/Debt	$-13M	$-2M
Current Ratio (TTM)	0.66x	2.14x
Quick Ratio (TTM)	0.47x	0.55x
Debt/Equity (TTM)	7.73x	0.87x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.51	-2.33
52W Performance	-81.1%	-85.6%
YTD Performance	-73.6%	-86.2%
% from 52W High	-82.5%	-92.1%
% from 52W Low	1.1%	5.4%
Efficiency & Yields
Asset Turnover (TTM)	0.88x	0.14x
FCF Yield (TTM)	-4.5%	-342.2%
Earnings Yield (TTM)	-8.4%	-221.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-17.4	-769.2
EV/GP/RG	0.53	0.04
Ticker research	View CTSO research	View FEMY research

Valuation

P/S Ratio

FEMY

2.31x

CTSO

5.84x

EV/FCF

CTSO

-23.75x

FEMY

-0.41x

Growth & revenue

Revenue Growth TTM

FEMY

21.9%

CTSO

8.6%

Forward Revenue Growth

FEMY

297.9%

CTSO

13.6%

Profitability & performance

Gross Margin

CTSO

71.6%

FEMY

61.0%

ROE

CTSO

-16513.0%

FEMY

-21646.0%

FCF Yield %

CTSO

-4.5%

FEMY

-342.2%

52-Week Performance

CTSO

-81.1%

FEMY

-85.6%

Detailed metrics comparison

CTSO

Cytosorbents Corp

FEMY

Femasys Inc

Market Cap

CTSO$217M

FEMY$5M

Enterprise Value

CTSO$230M

FEMY$7M

Price

CTSO$3.46

FEMY$1.76

P/E Ratio

CTSON/A

FEMYN/A

P/S Ratio

CTSO5.84x

FEMY2.31x

EV/Sales

CTSO6.19x

FEMY3.22x

EV/EBITDA

CTSO0.00x

FEMY0.00x

P/B Ratio

CTSO5.44x

FEMY4.16x

P/FCF Ratio

CTSON/A

FEMYN/A

EV/FCF

CTSO-23.75x

FEMY-0.41x

PEG Ratio

CTSON/A

FEMYN/A

Forward P/E (NTM)

CTSON/A

FEMYN/A

Forward P/S (NTM)

CTSO5.02x

FEMY0.95x

Revenue (TTM)

CTSO$37M

FEMY$2M

Revenue Growth (YoY)

CTSO8.6%

FEMY21.9%

Forward Rev Growth

CTSO13.6%

FEMY297.9%

Gross Margin (TTM)

CTSO71.6%

FEMY61.0%

Operating Margin (TTM)

CTSO0.0%

FEMY0.0%

EBITDA Margin (TTM)

CTSO-28.3%

FEMY-749.3%

Net Margin (TTM)

CTSO-48.9%

FEMY-511.8%

FCF Margin (TTM)

CTSO-26.0%

FEMY-791.0%

Net Income (TTM)

CTSO$-18M

FEMY$-12M

FCF (TTM)

CTSO$-10M

FEMY$-18M

EPS (TTM)

CTSO-$0.29

FEMY-$3.51

ROE (TTM)

CTSO-16513.0%

FEMY-21646.0%

ROA (TTM)

CTSO-4325.0%

FEMY-7154.0%

ROIC (TTM)

CTSO-5193.0%

FEMY-12206.0%

Cash

CTSO$4M

FEMY$1M

Debt

CTSO$17M

FEMY$4M

Net Cash/Debt

CTSO$-13M

FEMY$-2M

Current Ratio (TTM)

CTSO0.66x

FEMY2.14x

Quick Ratio (TTM)

CTSO0.47x

FEMY0.55x

Debt/Equity (TTM)

CTSO7.73x

FEMY0.87x

Debt/Assets (TTM)

CTSO0.0%

FEMY0.0%

Interest Coverage (TTM)

CTSON/A

FEMYN/A

Net Debt/EBITDA (TTM)

CTSO0.00x

FEMY0.00x

Beta

CTSO1.51

FEMY-2.33

52W Performance

CTSO-81.1%

FEMY-85.6%

YTD Performance

CTSO-73.6%

FEMY-86.2%

% from 52W High

CTSO-82.5%

FEMY-92.1%

% from 52W Low

CTSO1.1%

FEMY5.4%

Asset Turnover (TTM)

CTSO0.88x

FEMY0.14x

FCF Yield (TTM)

CTSO-4.5%

FEMY-342.2%

Earnings Yield (TTM)

CTSO-8.4%

FEMY-221.4%

Dividend Yield (TTM)

CTSON/A

FEMYN/A

Rule of 40

CTSO-17.4

FEMY-769.2

EV/GP/RG

CTSO0.53

FEMY0.04

Ticker research

View CTSO research View FEMY research

Metric	CTSO Cytosorbents Corp	FEMY Femasys Inc
Market & Valuation
Market Cap	$217M	$5M
Enterprise Value	$230M	$7M
Price	$3.46	$1.76
P/E Ratio	N/A	N/A
P/S Ratio	5.84x	2.31x
EV/Sales	6.19x	3.22x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.44x	4.16x
P/FCF Ratio	N/A	N/A
EV/FCF	-23.75x	-0.41x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.02x	0.95x
Revenue & Growth
Revenue (TTM)	$37M	$2M
Revenue Growth (YoY)	8.6%	21.9%
Forward Rev Growth	13.6%	297.9%
Profitability
Gross Margin (TTM)	71.6%	61.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-28.3%	-749.3%
Net Margin (TTM)	-48.9%	-511.8%
FCF Margin (TTM)	-26.0%	-791.0%
Net Income (TTM)	$-18M	$-12M
FCF (TTM)	$-10M	$-18M
EPS (TTM)	-$0.29	-$3.51
ROE (TTM)	-16513.0%	-21646.0%
ROA (TTM)	-4325.0%	-7154.0%
ROIC (TTM)	-5193.0%	-12206.0%
Financial Health
Cash	$4M	$1M
Debt	$17M	$4M
Net Cash/Debt	$-13M	$-2M
Current Ratio (TTM)	0.66x	2.14x
Quick Ratio (TTM)	0.47x	0.55x
Debt/Equity (TTM)	7.73x	0.87x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.51	-2.33
52W Performance	-81.1%	-85.6%
YTD Performance	-73.6%	-86.2%
% from 52W High	-82.5%	-92.1%
% from 52W Low	1.1%	5.4%
Efficiency & Yields
Asset Turnover (TTM)	0.88x	0.14x
FCF Yield (TTM)	-4.5%	-342.2%
Earnings Yield (TTM)	-8.4%	-221.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-17.4	-769.2
EV/GP/RG	0.53	0.04
Ticker research	View CTSO research	View FEMY research